PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.
An Act Concerning Screening of Newborns for Lysosomal Storage Disorders
Be it enacted by the People of the State of Maine as follows:
Sec. 1.  22 MRSA §1533, sub-§2, ¶D-1  is enacted to read:
 
D-1.  Explore options for entering into contracts with other states to test samples collected during screening for lysosomal storage disorders;
Sec. 2. Department of Health and Human Services to amend rules on the newborn screening program. By January 1, 2016, the Department of Health and Human Services shall amend its rules in Chapter 283 relating to testing newborn infants for detection of causes of cognitive disabilities and congenital, genetic and metabolic disorders to include screening for the lysosomal storage disorders known as Krabbe, Pompe, Gaucher, Fabry and Niemann-Pick diseases.
 
SUMMARY
This bill requires the Department of Health and Human Services to amend its rules in Chapter 283 by January 1, 2016 to add to the newborn screening program the lysosomal storage disorders known as Krabbe, Pompe, Gaucher, Fabry and Niemann-Pick diseases. It authorizes the department to explore options to enter into contracts with other states to test samples collected for lysosomal storage disorders.